QSAR modeling to design selective histone deacetylase 8 (HDAC8) inhibitors.
Cao GP, Thangapandian S, Son M, Kumar R, Choi YJ, Kim Y, Kwon YJ, Kim HH, Suh JK, Lee KW.
Cao GP, et al. Among authors: kim hh, kim y.
Arch Pharm Res. 2016 Oct;39(10):1356-1369. doi: 10.1007/s12272-015-0705-5. Epub 2016 Aug 19.
Arch Pharm Res. 2016.
PMID: 27542119